Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Zero based budgeting for big families coordinates numerous expenses by prioritizing essentials, utilities, and savings while accommodating growth.
20,465 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
History isn’t a crystal ball, but it’s a powerful guide. Learn how the long arc of markets offers fantastic news for ...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Taiwan Semiconductor is in the spotlight as it signals higher capital spending. This article breaks down whether tsmc...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
A major government contract marks a turning point for Palantir. This analysis explains how the DHS deal could reshape...
Greg Abel is steering Berkshire’s AI strategy with a sizable move into Alphabet. This bold bet highlights how mega-ca...
A major advisory firm made a multi-million dollar bet in a large-cap growth ETF, catching the eye of everyday investo...
In markets, hacks chase quick bets while artists build sustainable growth. This guide shows how to blend both mindset...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...